Peter Kenemans
Department of Obstetrics and Gynaecology
VU University Medical Centre
Amsterdam
Netherlands
Name/email consistency: high
- Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial. Kenemans, P., Bundred, N.J., Foidart, J.M., Kubista, E., von Schoultz, B., Sismondi, P., Vassilopoulou-Sellin, R., Yip, C.H., Egberts, J., Mol-Arts, M., Mulder, R., van Os, S., Beckmann, M.W. Lancet Oncol. (2009)
- Oncogenic pathways in hereditary and sporadic breast cancer. Kenemans, P., Verstraeten, R.A., Verheijen, R.H. Maturitas (2008)
- Tibolone: clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group. Kenemans, P., Speroff, L. Maturitas (2005)
- Postmenopausal hormone therapy and breast cancer: what is the problem?. Kenemans, P. Maturitas (2005)
- Oncogenic pathways in hereditary and sporadic breast cancer. Kenemans, P., Verstraeten, R.A., Verheijen, R.H. Maturitas (2004)
- Breast cancer and post-menopausal hormone therapy. Kenemans, P., Bosman, A. Best Pract. Res. Clin. Endocrinol. Metab. (2003)